A unique private-public partnership, the Proton Therapy Center was built through a collaboration to develop and operate the investor-owned freestanding $125 million facility. M. D. Anderson provided the facility site, valued at $2.5 million and has full clinical, research and staffing responsibilities. Other investors and partners in the project include: Hitachi, Ltd. and Hitachi America, Ltd., supplying the proton therapy technology; Sanders Morris Harris, Inc. the largest investment bank and securities firm based in the Southwest; The Styles Co., a Houston-based project development and management firm specializing in health-care facilities; the Houston Firefighters' Relief and Retirement Fund and Houston Police Officers' Pension System, lead financial investors in the project; General Electric Company; Varian Medical Systems; and IMPAC Medical Systems.

Located at 1840 Old Spanish Trail near Fannin in the University of Texas Research Park, the Proton Therapy Center is part of M. D. Anderson's Red and Charline McCombs Institute for the Early Detection and Treatment of Cancer. Comprised of six centers focused on the study of genomics, metastasis, proteomics, immunology, diagnostic imaging and drug development, the Institute houses all research facilities except the Proton Therapy Center, which will be the sole patient care facility.


For more information on the Proton Therapy Center at M. D. Anderson, patients can call (866) 632-4PTC.

Back to HCB News

More Industry Headlines